The FDA quashes the company's hopes for accelerated approval of a key pipeline drug.
Compare TVTX Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
Travere Therapeutics, Inc.
News & Analysis: Travere Therapeutics, Inc.
RTRX earnings call for the period ending March 31, 2020.
RTRX earnings call for the period ending December 31, 2019.
RTRX earnings call for the period ending September 30, 2019.
Keeping up with the news from major medical meetings has become a requirement for healthcare investors.
Find out how earnings and other factors hit these stocks.
Retrophin's PKAN drug candidate missed the mark in a late-stage trial.
RTRX earnings call for the period ending June 30, 2019.
RTRX earnings call for the period ending March 31, 2019.
These two growth stocks are poised for enormous gains.